Concepts (141)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Hematopoietic Stem Cells | 8 | 2021 | 517 | 1.520 |
Why?
|
| Cell Proliferation | 6 | 2018 | 2397 | 0.760 |
Why?
|
| Cell Differentiation | 4 | 2016 | 1853 | 0.650 |
Why?
|
| Interferon-gamma | 3 | 2020 | 521 | 0.630 |
Why?
|
| Uveal Neoplasms | 3 | 2013 | 28 | 0.580 |
Why?
|
| Bromodeoxyuridine | 1 | 2018 | 56 | 0.550 |
Why?
|
| Basic-Leucine Zipper Transcription Factors | 1 | 2016 | 30 | 0.510 |
Why?
|
| Ubiquitin Thiolesterase | 3 | 2013 | 63 | 0.510 |
Why?
|
| Flow Cytometry | 1 | 2018 | 754 | 0.470 |
Why?
|
| Tumor Suppressor Proteins | 3 | 2013 | 478 | 0.420 |
Why?
|
| Melanocytes | 1 | 2013 | 44 | 0.410 |
Why?
|
| Melanoma | 3 | 2013 | 898 | 0.350 |
Why?
|
| Hematopoiesis | 3 | 2021 | 207 | 0.320 |
Why?
|
| DNA (Cytosine-5-)-Methyltransferases | 2 | 2021 | 148 | 0.300 |
Why?
|
| Cell Cycle | 3 | 2018 | 587 | 0.220 |
Why?
|
| Hematopoietic Cell Growth Factors | 1 | 2020 | 9 | 0.170 |
Why?
|
| Hematopoietic Stem Cell Mobilization | 1 | 2020 | 24 | 0.170 |
Why?
|
| Busulfan | 1 | 2020 | 46 | 0.170 |
Why?
|
| Cell Division | 2 | 2020 | 720 | 0.160 |
Why?
|
| Antigens, CD | 1 | 2020 | 415 | 0.150 |
Why?
|
| Membrane Glycoproteins | 1 | 2020 | 416 | 0.140 |
Why?
|
| Bone Marrow Cells | 2 | 2016 | 238 | 0.140 |
Why?
|
| Bone Marrow | 2 | 2020 | 309 | 0.140 |
Why?
|
| Cell Lineage | 2 | 2020 | 324 | 0.140 |
Why?
|
| Mice | 8 | 2021 | 17627 | 0.130 |
Why?
|
| Animals | 10 | 2021 | 33111 | 0.130 |
Why?
|
| Mycobacterium avium | 1 | 2016 | 16 | 0.130 |
Why?
|
| Cell Self Renewal | 1 | 2016 | 48 | 0.130 |
Why?
|
| RNA Interference | 3 | 2013 | 493 | 0.130 |
Why?
|
| Hemoglobinuria, Paroxysmal | 1 | 2016 | 21 | 0.120 |
Why?
|
| Proto-Oncogene Proteins c-kit | 1 | 2016 | 63 | 0.120 |
Why?
|
| GATA2 Transcription Factor | 1 | 2016 | 46 | 0.120 |
Why?
|
| Zinc Fingers | 1 | 2016 | 108 | 0.120 |
Why?
|
| Bone Marrow Diseases | 1 | 2016 | 41 | 0.120 |
Why?
|
| Anemia, Aplastic | 1 | 2016 | 58 | 0.120 |
Why?
|
| Protein Interaction Domains and Motifs | 1 | 2016 | 133 | 0.120 |
Why?
|
| Thrombocythemia, Essential | 1 | 2015 | 33 | 0.110 |
Why?
|
| Polycythemia Vera | 1 | 2015 | 41 | 0.110 |
Why?
|
| CCAAT-Enhancer-Binding Proteins | 1 | 2014 | 39 | 0.110 |
Why?
|
| Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2015 | 102 | 0.110 |
Why?
|
| Hydroxyurea | 1 | 2015 | 86 | 0.110 |
Why?
|
| Myeloid Cells | 1 | 2014 | 106 | 0.110 |
Why?
|
| Sequence Deletion | 1 | 2016 | 511 | 0.100 |
Why?
|
| Host Cell Factor C1 | 1 | 2013 | 10 | 0.100 |
Why?
|
| Homeostasis | 1 | 2018 | 689 | 0.100 |
Why?
|
| Interferon-alpha | 1 | 2015 | 237 | 0.100 |
Why?
|
| Signal Transduction | 2 | 2016 | 4478 | 0.100 |
Why?
|
| Cell Line, Tumor | 4 | 2013 | 3499 | 0.100 |
Why?
|
| Heterografts | 1 | 2013 | 190 | 0.100 |
Why?
|
| Cluster Analysis | 1 | 2013 | 408 | 0.090 |
Why?
|
| Protein Binding | 2 | 2013 | 1663 | 0.090 |
Why?
|
| Histone Deacetylase Inhibitors | 1 | 2011 | 79 | 0.090 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2020 | 1170 | 0.080 |
Why?
|
| Neoplastic Stem Cells | 1 | 2013 | 331 | 0.080 |
Why?
|
| Retinoblastoma Protein | 1 | 2010 | 76 | 0.080 |
Why?
|
| p38 Mitogen-Activated Protein Kinases | 1 | 2010 | 119 | 0.080 |
Why?
|
| Proto-Oncogene Proteins c-mdm2 | 1 | 2010 | 80 | 0.080 |
Why?
|
| Cell Transformation, Neoplastic | 1 | 2013 | 606 | 0.080 |
Why?
|
| Mice, Inbred C57BL | 2 | 2020 | 4511 | 0.080 |
Why?
|
| Neoplasm Metastasis | 1 | 2010 | 686 | 0.070 |
Why?
|
| Gammaherpesvirinae | 1 | 2007 | 6 | 0.070 |
Why?
|
| Disease Models, Animal | 2 | 2016 | 4442 | 0.060 |
Why?
|
| Reproducibility of Results | 1 | 2013 | 2886 | 0.060 |
Why?
|
| Gene Expression Profiling | 1 | 2013 | 1760 | 0.060 |
Why?
|
| Protein Kinases | 1 | 2007 | 318 | 0.060 |
Why?
|
| Humans | 9 | 2020 | 126923 | 0.060 |
Why?
|
| DNA Damage | 1 | 2007 | 498 | 0.050 |
Why?
|
| Apoptosis | 1 | 2010 | 1811 | 0.050 |
Why?
|
| Phenotype | 1 | 2013 | 4305 | 0.050 |
Why?
|
| Histones | 1 | 2007 | 503 | 0.050 |
Why?
|
| Mutation | 2 | 2021 | 5944 | 0.050 |
Why?
|
| Liver Neoplasms | 1 | 2013 | 1351 | 0.050 |
Why?
|
| Antineoplastic Agents | 1 | 2011 | 1758 | 0.050 |
Why?
|
| Bone Marrow Stromal Antigen 2 | 1 | 2020 | 12 | 0.040 |
Why?
|
| E-Selectin | 1 | 2020 | 38 | 0.040 |
Why?
|
| Chemokine CXCL12 | 1 | 2020 | 34 | 0.040 |
Why?
|
| Radiation Chimera | 1 | 2020 | 17 | 0.040 |
Why?
|
| GPI-Linked Proteins | 1 | 2020 | 104 | 0.040 |
Why?
|
| Clone Cells | 1 | 2020 | 163 | 0.040 |
Why?
|
| Fluorouracil | 1 | 2020 | 132 | 0.040 |
Why?
|
| Decalcification, Pathologic | 1 | 2016 | 2 | 0.030 |
Why?
|
| Side-Population Cells | 1 | 2016 | 12 | 0.030 |
Why?
|
| Chromatin Immunoprecipitation | 1 | 2016 | 229 | 0.030 |
Why?
|
| Mice, Transgenic | 1 | 2020 | 2311 | 0.030 |
Why?
|
| Phosphorylation | 2 | 2010 | 1536 | 0.030 |
Why?
|
| Immunophenotyping | 1 | 2016 | 330 | 0.030 |
Why?
|
| Genes, Reporter | 1 | 2016 | 345 | 0.030 |
Why?
|
| Janus Kinase 2 | 1 | 2015 | 135 | 0.030 |
Why?
|
| Gene Frequency | 1 | 2016 | 737 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2016 | 294 | 0.030 |
Why?
|
| Neoplasm Micrometastasis | 1 | 2011 | 13 | 0.020 |
Why?
|
| Chemoradiotherapy, Adjuvant | 1 | 2011 | 26 | 0.020 |
Why?
|
| Hydroxamic Acids | 1 | 2011 | 57 | 0.020 |
Why?
|
| Gene Expression | 1 | 2016 | 1482 | 0.020 |
Why?
|
| Male | 2 | 2015 | 62623 | 0.020 |
Why?
|
| Mice, Inbred NOD | 1 | 2011 | 289 | 0.020 |
Why?
|
| Tumor Burden | 1 | 2011 | 229 | 0.020 |
Why?
|
| Valproic Acid | 1 | 2011 | 161 | 0.020 |
Why?
|
| Mitogen-Activated Protein Kinase 14 | 1 | 2010 | 8 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2010 | 49 | 0.020 |
Why?
|
| Gene Knockdown Techniques | 1 | 2011 | 372 | 0.020 |
Why?
|
| High-Throughput Nucleotide Sequencing | 1 | 2016 | 899 | 0.020 |
Why?
|
| RNA, Neoplasm | 1 | 2010 | 128 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2010 | 89 | 0.020 |
Why?
|
| Etoposide | 1 | 2010 | 109 | 0.020 |
Why?
|
| Indoles | 1 | 2011 | 199 | 0.020 |
Why?
|
| Mice, SCID | 1 | 2011 | 570 | 0.020 |
Why?
|
| E2F1 Transcription Factor | 1 | 2010 | 48 | 0.020 |
Why?
|
| Cyclin-Dependent Kinase 4 | 1 | 2010 | 62 | 0.020 |
Why?
|
| Purines | 1 | 2010 | 111 | 0.020 |
Why?
|
| Immunoblotting | 1 | 2010 | 291 | 0.020 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2010 | 101 | 0.020 |
Why?
|
| Genotype | 1 | 2016 | 2597 | 0.020 |
Why?
|
| Serine | 1 | 2010 | 160 | 0.020 |
Why?
|
| Frameshift Mutation | 1 | 2010 | 190 | 0.020 |
Why?
|
| Protein Structure, Tertiary | 1 | 2010 | 720 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2011 | 946 | 0.020 |
Why?
|
| Computer Simulation | 1 | 2011 | 665 | 0.020 |
Why?
|
| Germ-Line Mutation | 1 | 2010 | 352 | 0.020 |
Why?
|
| Mice, Knockout | 1 | 2016 | 3710 | 0.020 |
Why?
|
| Chromosome Deletion | 1 | 2010 | 642 | 0.020 |
Why?
|
| Gene Expression Regulation | 1 | 2016 | 2309 | 0.020 |
Why?
|
| Open Reading Frames | 1 | 2007 | 201 | 0.020 |
Why?
|
| Models, Biological | 1 | 2011 | 1373 | 0.020 |
Why?
|
| Biomarkers | 1 | 2016 | 3223 | 0.020 |
Why?
|
| Prognosis | 1 | 2016 | 4775 | 0.020 |
Why?
|
| Plasmids | 1 | 2007 | 445 | 0.020 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2010 | 727 | 0.020 |
Why?
|
| Herpesviridae Infections | 1 | 2007 | 139 | 0.020 |
Why?
|
| Mutation, Missense | 1 | 2010 | 891 | 0.020 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2010 | 576 | 0.020 |
Why?
|
| Viral Proteins | 1 | 2007 | 336 | 0.010 |
Why?
|
| Time Factors | 1 | 2015 | 6147 | 0.010 |
Why?
|
| Phosphoproteins | 1 | 2007 | 420 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2010 | 2538 | 0.010 |
Why?
|
| Sequence Analysis, DNA | 1 | 2010 | 1707 | 0.010 |
Why?
|
| Herpesvirus 4, Human | 1 | 2007 | 615 | 0.010 |
Why?
|
| Virus Replication | 1 | 2007 | 593 | 0.010 |
Why?
|
| Aged | 1 | 2015 | 20395 | 0.010 |
Why?
|
| Middle Aged | 1 | 2015 | 27758 | 0.010 |
Why?
|
| Female | 1 | 2015 | 68418 | 0.000 |
Why?
|